Angelo Tzarevski

Angelo provides strategic advice to multinational corporations on complex cross-border merger control cases, complaint proceedings involving prohibited practices and abuse of dominance, compliance, and corporate leniency. He has been involved in some of the most high-profile and complex matters, including for clients such as GlaxoSmithKline, Bayer, Archer-Daniels- Midland, Chr. Hansen, Daimler Group, Haleon, Sika AG, Suez Group, Unilever, Hitachi and Bausch Health Companies, among others.

Angelo represents clients before antitrust & competition regulators in across sub-Saharan Africa, including South Africa, Botswana, Egypt, Ethiopia, Kenya, Malawi, Morocco, Mozambique, Namibia, Nigeria, Tanzania, Uganda, Zambia, Zimbabwe, as well as the Common Market of Southern and Eastern Africa (COMESA) and the Central African Economic and Monetary Community (CEMAC).

Angelo's experience covers a diverse range of industries including pharmaceuticals, healthcare, banking and financial services, private equity, oil and gas, Big Tech, luxury consumer goods, aviation, shipping, and automotive.

Transactions

• ZCCM Investments Holdings Plc on the African merger control aspects of its disposal of a 51% interest in Mopani Copper Mines plc, in a strategic transaction for Zambia's copper mining industry, valued at USD 1.1 billion.

• Hong Kong based conglomerate corporation on the merger control aspects of its joint venture for the construction and operation of a major shipping port in Egypt valued at USD 700 million.

• Sika AG on the African merger control aspects of its acquisition of MBCC Group from an affiliate of Lone Star Funds, valued at USD 5.2 billion.

• Suez Group and its consortium partners Royal Bafokeng Holdings and African Infrastructure Investment Managers, in successfully obtaining merger clearance in South Africa and Mozambique for the acquisition of control over EnviroServ, one of the largest waste treatment and disposal companies in the region.

• Blantyre Capital and Greenpoint Capital on the merger control aspects of their joint acquisition of control over Ster-Kinekor Theatres, one of South Africa's largest cinema chains, which facilitated Ster-Kinekor's emergence from business rescue.

• Hitachi, Inc. in successfully obtaining merger clearance in South Africa and Namibia in respect of its global acquisition of the power grid business of Swiss-based ABB Ltd. valued at USD 11 billion.

• GlaxoSmithKline in obtaining merger clearance in South Africa for its USD 12.7 billion acquisition of the global consumer healthcare business of Pfizer, Inc.

• Bayer AG on the South African merger control aspects of the disposal of its animal health business to Elanco Animal Health Inc. in a global transaction valued at USD 7 billion.

• Archer-Daniels-Midland on the Malagasy merger control aspects of a series of transactions involving a full-function joint venture.

• Russian vertically integrated steel making and mining company in successfully blocking the hostile takeover of its South African businesses.

• Archer-Daniels-Midland in successfully obtaining clearance in South Africa for its EUR 1.5 billion acquisition of Neovia.

• Bausch Health Companies Inc. (formerly Valeant Pharmaceuticals), a multinational specialty pharmaceutical company, in successfully obtaining merger approval in South Africa and Namibia for the sale of its global subsidiary, iNova Pharmaceuticals, to a private equity consortium for USD 930 million.

Antitrust / Regulatory

• Unilever in relation to defending and ultimately successfully settling (with no admission of liability) complaint proceedings by the South African antitrust authorities involving allegations of cartel conduct.

• Japan-based global automotive parts supplier in successfully negotiating settlement of cartel proceedings instituted by the South African competition regulator with no admission of liability.

• US-based global athletic footwear and apparel corporation in ongoing complaint proceedings by the South African competition regulator in relation to various distribution arrangements.

• US-based global media agency in relation to ongoing immunity applications to the South African competition regulator.

• International conglomerate in relation to antitrust claims instituted by the purchasers of its former media business who are facing ongoing investigations and prosecutions by the South African competition authorities.

• International Bar Association - Member
• Law Society of South Africa - Member